SwissVaccinationPlanImmunizations

CH VACD Swiss Vaccination Plan Immunizations

activeCH Term (R4)3.3.030 concepts

Immunization procedures for recommendations according to the vaccination plan.

Metadata

hl7.org/fhir
Canonical URL
http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-ch-vaccination-plan-immunizations-vs
ID
ch-vacd-ch-vaccination-plan-immunizations-vs
Name
SwissVaccinationPlanImmunizations

http://snomed.info/sct

30 codes
CodeDisplay
42284007Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure)
76668005Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure)
127787002Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure)
243789007Administration of vaccine product containing only Hepatitis A virus antigen (procedure)
16584000Administration of vaccine product containing only Hepatitis B virus antigen (procedure)
86198006Administration of vaccine product containing only Influenza virus antigen (procedure)
314759000Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure)
47435007Administration of vaccine product containing only Measles morbillivirus antigen (procedure)
719596001Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure)
314417000Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure)
871874000Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure)
50583002Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure)
761841000Administration of vaccine product containing only Human papillomavirus antigen (procedure)
39343008Administration of vaccine product containing only Bordetella pertussis antigen (procedure)
1119368005Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure)
1119366009Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure)
1119367000Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure)
72093006Administration of vaccine product containing only Human poliovirus antigen (procedure)
34631000Administration of vaccine product containing only Rabies lyssavirus antigen (procedure)
82314000Administration of vaccine product containing only Rubella virus antigen (procedure)
127786006Administration of vaccine product containing only Clostridium tetani antigen (procedure)
281658005Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure)
15483003Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure)
737081007Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)
722215002Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure)
67308009Administration of vaccine product containing only Yellow fever virus antigen (procedure)
1157107003Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
1119350007Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
1209198003Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure)
1162645008Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)